Evidence map›Paper›PMID 33071044›Full record

ReviewCytokine & growth factor reviews2021

Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.

Lucia Gabriele, Alessandra Fragale, Giulia Romagnoli, Stefania Parlato, Caterina Lapenta, Stefano Maria Santini, Keiko Ozato, Imerio Capone

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine & growth factor reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Unraveled role of TLR7-mediated interferon signaling activation in COVID-19.Frontiers in cellular and infection microbiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lucia GabrieleDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address: lucia.gabriele@iss.it.
Alessandra FragaleDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Giulia RomagnoliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Stefania ParlatoDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Caterina LapentaDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Stefano Maria SantiniDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Keiko OzatoDivision of Developmental Biology, National Institute of Child Health and Human Development, Bethesda, MD, USA.
Imerio CaponeDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address: imerio.capone@iss.it.
Istituto Superiore di Sanità · ITEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Chromatin and epigenetic memory ZIAHD008815 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI OZATO, KEIKO · 2009 to 2025
$16.2M
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, induces severe pneumonia mainly in elderly males. Epidemiological data clearly indicate sex-based differences in disease outcomes, with men accounting for about 70 % of deaths, despite similar susceptibility to infection. It is well known that females are endowed with higher capacity to produce antibodies, which correlates with viral clearance and disease resolution in the context of SARS-Cov-2 infection. Many X-linked immune genes escape X inactivation showing biallelic expression in female immune cells, particularly in plasmacytoid dendritic cells (pDCs). PDCs are more active in females and endowed with high capability to induce IFN-α-mediated B cell activation and differentiation into antibody-producing plasma cells throughout epigenetic mechanisms linked to trained immunity. Thus, we hypothesize that following SARS-CoV-2 infection, epigenetic modifications of X-linked genes involved in pDC-mediated type I IFN (IFN-I) signaling occurs more effectively in females, for inducing neutralizing antibody response as an immune correlate driving sex-biased disease outcome.

Indexed as

Antibody FormationCOVID-19FemaleHumansInterferon Type IMalePandemicsPrognosisSARS-CoV-2Sex CharacteristicsInterferon Type IAntibody responseCOVID-19Plasmacytoid dendritic cellsSex-dimorphismType I IFN

Identifiers

PMID33071044
PMCPMC7543933
OpenAlexW3092455373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.